Login to Your Account


Chilean scientists developing melanoma vaccine for trials in Cuba

By Sergio Held
Staff Writer

Thursday, February 5, 2015

Chilean researchers from the Instituto Milenio en Inmunología e Inmunoterapia (IMII) are developing a vaccine targeting melanoma, as well as vaccines for infectious agents of high impact on public health. IMII said the cancer vaccine will be tested in Cuba.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription